NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
Abstract:
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Public/Granted literature
Information query
Patent Agency Ranking
0/0